Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-21

Clinical Trial Update: Tissue Kallikrein Protect Against Ischemic Stroke

View source ↗

Summary

A completed clinical trial evaluating tissue kallikrein for protection against ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tissue kallikrein (tissue kallikrein)

Snippet

Sponsor: Qin Zhang | Conditions: Stroke, Ischemic | Status: COMPLETED